Toxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell cancer

Nicolas Acquavella, Harriet Kluger, John Rhee, Leonard Farber, Harold Tara, Stephan Ariyan, Deepak Narayan, William Kelly, Mario Sznol

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Toxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences